
Before Sorcero wrote its future in code, its CEO listened to hundreds of people doing the work. Her story is a useful argument for patient research, vertical focus and technology built in service of expert judgment.
Medical teams at drug companies read maybe 10% of the evidence that matters. Sorcero built AI agents to read the other 90% - and about a third of the top 30 global pharma companies are now paying for it.